The presence of disseminated tumour cells in the bone marrow is inversely related to circulating free DNA in plasma in breast cancer dormancy
Open Access
- 13 December 2011
- journal article
- research article
- Published by Springer Nature in British Journal of Cancer
- Vol. 106 (2) , 375-382
Abstract
The aim of this study was to gain insight into breast cancer dormancy by examining different measures of minimal residual disease (MRD) over time in relation to known prognostic factors. Sixty-four primary breast cancer patients on follow-up (a median of 8.3 years post surgery) who were disease free had sequential bone marrow aspirates and blood samples taken for the measurement of disseminated tumour cells (DTCs), circulating tumour cells (CTCs) by CellSearch and qPCR measurement of overlapping (96-bp and 291-bp) amplicons in circulating free DNA (cfDNA). The presence of CTCs was correlated with the presence of DTCs measured by immunocytochemistry (P=0.01) but both were infrequently detected. Increasing cfDNA concentration correlated with ER, HER2 and triple-negative tumours and high tumour grade, and the 291-bp amplicon was inversely correlated with DTCs measured by CK19 qRT-PCR (P=0.047). Our results show that breast cancer patients have evidence of MRD for many years after diagnosis despite there being no overt evidence of disease. The inverse relationship between bone marrow CK19 mRNA and the 291-bp amplicon in cfDNA suggests that an inverse relationship between a measure of cell viability in the bone marrow (DTCs) and cell death in the plasma occurs during the dormancy phase of breast cancer.Keywords
This publication has 31 references indexed in Scilit:
- Genomic analysis of circulating cell-free DNA infers breast cancer dormancyGenome Research, 2011
- Detection of HER2 amplification in circulating free DNA in patients with breast cancerBritish Journal of Cancer, 2011
- Are breast conservation and mastectomy equally effective in the treatment of young women with early breast cancer? Long-term results of a population-based cohort of 1,451 patients aged ≤40 yearsBreast Cancer Research and Treatment, 2010
- Comparative evaluation of cell-free tumor DNA in blood and disseminated tumor cells in bone marrow of patients with primary breast cancerBreast Cancer Research, 2009
- The presence of circulating total DNA and methylated genes is associated with circulating tumour cells in blood from breast cancer patientsBritish Journal of Cancer, 2009
- Transcriptional Switch of Dormant Tumors to Fast-Growing Angiogenic PhenotypeCancer Research, 2009
- Comparison of bone marrow, disseminated tumour cells and blood-circulating tumour cells in breast cancer patients after primary treatmentBritish Journal of Cancer, 2008
- Bone marrow cytokeratin 19 mRNA level is an independent predictor of relapse-free survival in operable breast cancer patientsBreast Cancer Research and Treatment, 2007
- A Pooled Analysis of Bone Marrow Micrometastasis in Breast CancerNew England Journal of Medicine, 2005
- Dormancy of micrometastases: Balanced proliferation and apoptosis in the presence of angiogenesis suppressionNature Medicine, 1995